Showing results (521-530 of 644) with videos related to

Sort By:
Pageof 65
HIV Medicine|July 19, 2017
The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trialJ Tiraboschi, S Ray, K Patel, et al.
Frontiers in Psychiatry|June 17, 2022
Transcranial Magnetic Stimulation for Post-traumatic Stress DisorderAmber N Edinoff, Tanner L Hegefeld, Murray Petersen, et al.
Infection Control and Hospital Epidemiology|July 5, 2012
Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardshipDror Marchaim, Teena Chopra, Ashish Bhargava, et al.
Msphere|October 22, 2020
Humidity and Deposition Solution Play a Critical Role in Virus Inactivation by Heat Treatment of N95 RespiratorsNicole Rockey, Peter J Arts, Lucinda Li, et al.
Open Forum Infectious Diseases|March 11, 2020
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 StudyMichelle L Brown, Johann Motsch, Keith S Kaye, et al.
Health Psychology Research|October 20, 2022
Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive reviewElyse M Cornett, Meskerem A Nemomsa, Bailey Turbeville, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2023
An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent InfectionsKrishna Rao, Qianzi Zhao, Justin Bell, et al.
Lancet (London, England)|November 5, 1997
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating CommitteeF Brun-Vézinet, C Boucher, C Loveday, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 25, 2025
How do I manage Difficult-to-Treat Pseudomonas aeruginosa infections?: Key Questions for Today's CliniciansJuan P Horcajada, Ana Gales, Burcu Isler, et al.
Infection Control and Hospital Epidemiology|March 8, 2014
Statewide surveillance of carbapenem-resistant enterobacteriaceae in MichiganBrenda M Brennan, Joseph R Coyle, Dror Marchaim, et al.
Pageof 65